- Home
- SOPH vs TIL Comparison
SOPH vs TIL Comparison
Compare SOPH & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOPH
- TIL
- Stock Information
- Founded
- SOPH 2011
- TIL 2018
- Country
- SOPH Switzerland
- TIL United States
- Employees
- SOPH N/A
- TIL N/A
- Industry
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- SOPH Health Care
- TIL Health Care
- Exchange
- SOPH Nasdaq
- TIL Nasdaq
- Market Cap
- SOPH 206.6M
- TIL 171.7M
- IPO Year
- SOPH 2021
- TIL 2021
- Fundamental
- Price
- SOPH $2.83
- TIL $15.46
- Analyst Decision
- SOPH Strong Buy
- TIL Buy
- Analyst Count
- SOPH 2
- TIL 5
- Target Price
- SOPH $6.50
- TIL $114.00
- AVG Volume (30 Days)
- SOPH 36.0K
- TIL 78.2K
- Earning Date
- SOPH 05-06-2025
- TIL 05-09-2025
- Dividend Yield
- SOPH N/A
- TIL N/A
- EPS Growth
- SOPH N/A
- TIL N/A
- EPS
- SOPH N/A
- TIL N/A
- Revenue
- SOPH $65,173,000.00
- TIL N/A
- Revenue This Year
- SOPH $14.83
- TIL N/A
- Revenue Next Year
- SOPH $22.79
- TIL N/A
- P/E Ratio
- SOPH N/A
- TIL N/A
- Revenue Growth
- SOPH 4.49
- TIL N/A
- 52 Week Low
- SOPH $2.60
- TIL $9.62
- 52 Week High
- SOPH $6.28
- TIL $92.00
- Technical
- Relative Strength Index (RSI)
- SOPH 42.78
- TIL 44.19
- Support Level
- SOPH $2.60
- TIL $14.96
- Resistance Level
- SOPH $3.00
- TIL $18.71
- Average True Range (ATR)
- SOPH 0.32
- TIL 1.80
- MACD
- SOPH -0.00
- TIL 0.09
- Stochastic Oscillator
- SOPH 25.84
- TIL 46.32
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.